Results
|
1.
|
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients. [electronic resource] by
- Sklavenitis-Pistofidis, Romanos
- Capelletti, Marzia
- Liu, Chia-Jen
- Reidy, Mairead
- Zavidij, Oksana
- Huynh, Daisy
- Henrick, Patrick
- Savell, Alexandra
- Reyes, Kaitlen
- Rivotto, Bradley
- Bustoros, Mark
- Perilla-Glen, Adriana
- Trippa, Lorenzo
- Castillo, Jorge J
- Treon, Steven P
- Ghobrial, Irene M
Producer: 20190716
In:
Blood vol. 132
Availability: No items available.
|
|
2.
|
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma. [electronic resource] by
- Ghobrial, Irene M
- Liu, Chia-Jen
- Redd, Robert A
- Perez, Raymond P
- Baz, Rachid
- Zavidij, Oksana
- Sklavenitis-Pistofidis, Romanos
- Richardson, Paul G
- Anderson, Kenneth C
- Laubach, Jacob
- Henrick, Patrick
- Savell, Alexandra
- Reyes, Kaitlen
- Hornburg, Kalvis
- Chuma, Stacey
- Sabbatini, Peter
- Robbins, Michael D
- Becker, Pamela S
Producer: 20201001
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|
|
3.
|
Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1-1b study. [electronic resource] by
- Davids, Matthew S
- Kim, Haesook T
- Nicotra, Alyssa
- Savell, Alexandra
- Francoeur, Karen
- Hellman, Jeffrey M
- Bazemore, Josie
- Miskin, Hari P
- Sportelli, Peter
- Stampleman, Laura
- Maegawa, Rodrigo
- Rueter, Jens
- Boruchov, Adam M
- Arnason, Jon E
- Jacobson, Caron A
- Jacobsen, Eric D
- Fisher, David C
- Brown, Jennifer R
Producer: 20190205
In:
The Lancet. Haematology vol. 6
Availability: No items available.
|
|
4.
|
Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial. [electronic resource] by
- Davids, Matthew S
- Brander, Danielle M
- Kim, Haesook T
- Tyekucheva, Svitlana
- Bsat, Jad
- Savell, Alexandra
- Hellman, Jeffrey M
- Bazemore, Josie
- Francoeur, Karen
- Alencar, Alvaro
- Shune, Leyla
- Omaira, Mohammad
- Jacobson, Caron A
- Armand, Philippe
- Ng, Samuel
- Crombie, Jennifer
- LaCasce, Ann S
- Arnason, Jon
- Hochberg, Ephraim P
- Takvorian, Ronald W
- Abramson, Jeremy S
- Fisher, David C
- Brown, Jennifer R
Producer: 20191030
In:
The Lancet. Haematology vol. 6
Availability: No items available.
|
|
5.
|
A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma. [electronic resource] by
- Laubach, Jacob P
- Liu, Chia-Jen
- Raje, Noopur S
- Yee, Andrew J
- Armand, Philippe
- Schlossman, Robert L
- Rosenblatt, Jacalyn
- Hedlund, Jacquelyn
- Martin, Michael
- Reynolds, Craig
- Shain, Kenneth H
- Zackon, Ira
- Stampleman, Laura
- Henrick, Patrick
- Rivotto, Bradley
- Hornburg, Kalvis T V
- Dumke, Henry J
- Chuma, Stacey
- Savell, Alexandra
- Handisides, Damian R
- Kroll, Stew
- Anderson, Kenneth C
- Richardson, Paul G
- Ghobrial, Irene M
Producer: 20200219
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
6.
|
Ipilimumab for Patients with Relapse after Allogeneic Transplantation. [electronic resource] by
- Davids, Matthew S
- Kim, Haesook T
- Bachireddy, Pavan
- Costello, Caitlin
- Liguori, Rebecca
- Savell, Alexandra
- Lukez, Alexander P
- Avigan, David
- Chen, Yi-Bin
- McSweeney, Peter
- LeBoeuf, Nicole R
- Rooney, Michael S
- Bowden, Michaela
- Zhou, Chensheng W
- Granter, Scott R
- Hornick, Jason L
- Rodig, Scott J
- Hirakawa, Masahiro
- Severgnini, Mariano
- Hodi, F Stephen
- Wu, Catherine J
- Ho, Vincent T
- Cutler, Corey
- Koreth, John
- Alyea, Edwin P
- Antin, Joseph H
- Armand, Philippe
- Streicher, Howard
- Ball, Edward D
- Ritz, Jerome
- Bashey, Asad
- Soiffer, Robert J
Producer: 20160720
In:
The New England journal of medicine vol. 375
Availability: No items available.
|